DiscoverJAMA Oncology Author InterviewsAtezolizumab in Combination With Carboplatin in Metastatic TNBC
Atezolizumab in Combination With Carboplatin in Metastatic TNBC

Atezolizumab in Combination With Carboplatin in Metastatic TNBC

Update: 2023-12-14
Share

Description

Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD.

Related Content:

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Atezolizumab in Combination With Carboplatin in Metastatic TNBC

Atezolizumab in Combination With Carboplatin in Metastatic TNBC